{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:18:35Z","timestamp":1790605115877,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbspin.2025.105934","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:47:13Z","timestamp":1750733233000},"page":"105934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-5729","authenticated-orcid":false,"given":"Marco","family":"Di Battista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tavanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Uggenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Chimera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carrozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"De Liperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Della Rossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jbspin.2025.105934_bib0205","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0210","doi-asserted-by":"crossref","first-page":"2302080","DOI":"10.1183\/13993003.02080-2023","article-title":"Mortality trends in idiopathic pulmonary fibrosis in Europe between 2013 and 2018","volume":"64","author":"Gonnelli","year":"2024","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jbspin.2025.105934_bib0215","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An Official ATS\/ERS\/JRS\/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0220","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RTI.0000000000000220","article-title":"Automated quantitative computed tomography versus visual computed tomography scoring in idiopathic pulmonary fibrosis validation against pulmonary function","volume":"31","author":"Jacob","year":"2016","journal-title":"J Thorac Imaging"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105934_bib0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.00071812","article-title":"Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis","volume":"43","author":"Maldonado","year":"2014","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jbspin.2025.105934_bib0235","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1007\/s00330-023-10010-w","article-title":"The effect of CALIPER-derived parameters for idiopathic pulmonary fibrosis in predicting prognosis, progression, and mortality: a systematic review","volume":"33","author":"Jiao yao","year":"2023","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0240","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10067-020-04938-3","article-title":"Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER","volume":"39","author":"Ferrazza","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0245","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/RTI.0000000000000659","article-title":"Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography","volume":"37","author":"Roncella","year":"2022","journal-title":"J Thorac Imaging"},{"issue":"17","key":"10.1016\/j.jbspin.2025.105934_bib0250","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.3390\/jcm10173812","article-title":"The extent and diverse trajectories of longitudinal changes in rheumatoid arthritis interstitial lung diseases using quantitative hrct scores","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jbspin.2025.105934_bib0255","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1007\/s00330-021-08485-6","article-title":"Lung vessel volume evaluated with CALIPER software is an independent predictor of mortality in COVID-19 patients: a multicentric retrospective analysis","volume":"32","author":"Romei","year":"2022","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0260","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/diagnostics14050550","article-title":"Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3-24-Month Follow-Up and Correlation with Functional Parameters","volume":"14","author":"Fanni","year":"2024","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.jbspin.2025.105934_bib0265","doi-asserted-by":"crossref","first-page":"e0310892","DOI":"10.1371\/journal.pone.0310892","article-title":"Quantitative chest computed tomography predicts mortality in systemic sclerosis: A longitudinal study","volume":"19","author":"Amorim","year":"2024","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.jbspin.2025.105934_bib0270","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jbspin.2025.105934_bib0275","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis\u2013Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jbspin.2025.105934_bib0280","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/rheumatology\/kead642","article-title":"Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease","volume":"63","author":"Di Battista","year":"2023","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0285","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis An Official ATS\/ERS\/JRS\/ALAT Clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jbspin.2025.105934_bib0290","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jbspin.2025.105934_bib0295","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0300","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/2397198320904178","article-title":"Patient-reported outcome measures in systemic sclerosis\u2013related interstitial lung disease for clinical practice and clinical trials","volume":"5","author":"Saketkoo","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"10.1016\/j.jbspin.2025.105934_bib0305","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.chest.2023.11.037","article-title":"Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification","volume":"165","author":"Brixey","year":"2024","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jbspin.2025.105934_bib0310","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1513\/AnnalsATS.201802-079OC","article-title":"Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II","volume":"15","author":"Goldin","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jbspin.2025.105934_bib0315","doi-asserted-by":"crossref","first-page":"e0213444","DOI":"10.1371\/journal.pone.0213444","article-title":"Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels","volume":"14","author":"Occhipinti","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0320","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.41085","article-title":"Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis\u2013Related Interstitial Lung Disease","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.jbspin.2025.105934_bib0325","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/j.crad.2021.11.006","article-title":"Prospective machine learning CT quantitative evaluation of idiopathic pulmonary fibrosis in patients undergoing anti-fibrotic treatment using low- and ultra-low-dose CT","volume":"77","author":"Koo","year":"2022","journal-title":"Clin Radiol"},{"issue":"9","key":"10.1016\/j.jbspin.2025.105934_bib0330","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/jcm8091469","article-title":"High-resolution CT Change over time in patients with idiopathic pulmonary fibrosis on antifibrotic treatment","volume":"8","author":"Balestro","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105934_bib0335","doi-asserted-by":"crossref","first-page":"1601011","DOI":"10.1183\/13993003.01011-2016","article-title":"Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures","volume":"49","author":"Jacob","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jbspin.2025.105934_bib0340","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00330-017-5053-z","article-title":"Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores","volume":"28","author":"Jacob","year":"2018","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0345","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/rheumatology\/keac311","article-title":"Lung vascular changes as biomarkers of severity in systemic sclerosis\u2013associated interstitial lung disease","volume":"62","author":"Bruni","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105934_bib0350","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/s41598-023-31470-6","article-title":"Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged>50 years","volume":"13","author":"John","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jbspin.2025.105934_bib0355","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/annrheumdis-2020-217359","article-title":"Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT","volume":"79","author":"Occhipinti","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jbspin.2025.105934_bib0360","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10456-024-09910-2","article-title":"The role of vasculature and angiogenesis in respiratory diseases","volume":"27","author":"Ackermann","year":"2024","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0365","doi-asserted-by":"crossref","first-page":"2004587","DOI":"10.1183\/13993003.04587-2020","article-title":"Effects of nintedanib by inclusion criteria for progression of interstitial lung disease","volume":"59","author":"Maher","year":"2022","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0370","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/rheumatology\/keac535","article-title":"Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: Data from the SENSCIS trial","volume":"62","author":"Denton","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jbspin.2025.105934_bib0375","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12931-020-1298-1","article-title":"Health-related quality of life and symptoms in patients with IPF treated with nintedanib: Analyses of patient-reported outcomes from the INPULSIS\u00ae trials","volume":"21","author":"Kreuter","year":"2020","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.jbspin.2025.105934_bib0380","doi-asserted-by":"crossref","first-page":"2300752","DOI":"10.1183\/13993003.00752-2023","article-title":"Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis","volume":"63","author":"Wijsenbeek","year":"2024","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0385","doi-asserted-by":"crossref","first-page":"e0251636","DOI":"10.1371\/journal.pone.0251636","article-title":"The safety of nintedanib for the treatment of interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Chen","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0390","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10787-023-01286-x","article-title":"Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects","volume":"31","author":"Di Battista","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.jbspin.2025.105934_bib0395","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00408-017-0035-0","article-title":"Novel Assessment of Interstitial Lung Disease Using the \u201cComputer-Aided Lung Informatics for Pathology Evaluation and Rating\u201d (CALIPER) Software System in Idiopathic Inflammatory Myopathies","volume":"195","author":"Ungprasert","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.jbspin.2025.105934_bib0400","doi-asserted-by":"crossref","first-page":"108852","DOI":"10.1016\/j.ejrad.2020.108852","article-title":"Automated Computed Tomography analysis in the assessment of Idiopathic Pulmonary Fibrosis severity and progression","volume":"124","author":"Romei","year":"2020","journal-title":"Eur J Radiol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2500096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2500096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:30:25Z","timestamp":1764257425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X2500096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1297319X2500096X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105934","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105934"}}